Literature DB >> 34007061

Intravitreal treatment for geographic atrophy: coming soon to a patient near you?

Christiana Dinah1, Jamie Enoch2, Arevik Ghulakhszian3, Deanna J Taylor2, David P Crabb2.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 34007061      PMCID： PMC9046256          DOI： 10.1038/s41433-021-01591-1

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN： 0950-222X            Impact factor:   4.456


× No keyword cloud information.
  25 in total

1.  Experiences of patients undergoing repeated intravitreal anti-vascular endothelial growth factor injections for neovascular age-related macular degeneration.

Authors:  Jessica Boyle; Meri Vukicevic; Konstandina Koklanis; Catherine Itsiopoulos; Gwyneth Rees
Journal:  Psychol Health Med       Date:  2017-01-09       Impact factor: 2.423

Review 2.  Experiences of patients undergoing anti-VEGF treatment for neovascular age-related macular degeneration: a systematic review.

Authors:  Jessica Boyle; Meri Vukicevic; Konstandina Koklanis; Catherine Itsiopoulos
Journal:  Psychol Health Med       Date:  2014-07-18       Impact factor: 2.423

3.  Change in area of geographic atrophy in the Age-Related Eye Disease Study: AREDS report number 26.

Authors:  Anne S Lindblad; Patricia C Lloyd; Traci E Clemons; Gary R Gensler; Frederick L Ferris; Michael L Klein; Jane R Armstrong
Journal:  Arch Ophthalmol       Date:  2009-09

4.  'You've got dry macular degeneration, end of story': a qualitative study into the experience of living with non-neovascular age-related macular degeneration.

Authors:  Deanna J Taylor; Lee Jones; Alison M Binns; David P Crabb
Journal:  Eye (Lond)       Date:  2019-05-22       Impact factor: 3.775

5.  Complement C3 Inhibitor Pegcetacoplan for Geographic Atrophy Secondary to Age-Related Macular Degeneration: A Randomized Phase 2 Trial.

Authors:  David S Liao; Federico V Grossi; Delphine El Mehdi; Monica R Gerber; David M Brown; Jeffrey S Heier; Charles C Wykoff; Lawrence J Singerman; Prema Abraham; Felix Grassmann; Peter Nuernberg; Bernhard H F Weber; Pascal Deschatelets; Robert Y Kim; Carol Y Chung; Ramiro M Ribeiro; Mohamed Hamdani; Philip J Rosenfeld; David S Boyer; Jason S Slakter; Cedric G Francois
Journal:  Ophthalmology       Date:  2019-07-16       Impact factor: 14.277

6.  Acceptability of healthcare interventions: an overview of reviews and development of a theoretical framework.

Authors:  Mandeep Sekhon; Martin Cartwright; Jill J Francis
Journal:  BMC Health Serv Res       Date:  2017-01-26       Impact factor: 2.655

7.  Action on neovascular age-related macular degeneration (nAMD): recommendations for management and service provision in the UK hospital eye service.

Authors:  Richard P Gale; Sajjad Mahmood; Helen Devonport; Praveen J Patel; Adam H Ross; Gavin Walters; Louise Downey; Samer El-Sherbiny; Mary Freeman; Simon Berry; Nitin Jain
Journal:  Eye (Lond)       Date:  2019-03       Impact factor: 3.775

8.  Measuring dynamic levels of self-perceived anxiety and concern during simulated mobility tasks in people with non-neovascular age-related macular degeneration.

Authors:  Deanna J Taylor; Nicholas D Smith; Pete R Jones; Alison M Binns; David P Crabb
Journal:  Br J Ophthalmol       Date:  2019-07-09       Impact factor: 4.638

9.  Acceptability of intravitreal injections in geographic atrophy: protocol for a mixed-methods pilot study.

Authors:  Jamie Enoch; Arevik Ghulakhszian; David P Crabb; Christiana Dinah; Deanna J Taylor
Journal:  BMJ Open       Date:  2021-04-24       Impact factor: 2.692

10.  C5 Inhibitor Avacincaptad Pegol for Geographic Atrophy Due to Age-Related Macular Degeneration: A Randomized Pivotal Phase 2/3 Trial.

Authors:  Glenn J Jaffe; Keith Westby; Karl G Csaky; Jordi Monés; Joel A Pearlman; Sunil S Patel; Brian C Joondeph; John Randolph; Harvey Masonson; Kourous A Rezaei
Journal:  Ophthalmology       Date:  2020-09-01       Impact factor: 12.079
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.